Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLOBAL LEADERS Adjudication Sub-Study

NCT03231059 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT03231059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03231059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLOBAL LEADERS Adjudication Sub-Study
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Completed
Start date
June 1, 2017
Completion date
May 30, 2020
Enrollment
7,365 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, platelet-aggregation inhibitors